NDC product
PHENYLEPHRINE HCI
NDC 51662-1249 · HF Acquisition Co LLC, DBA HealthFirst
Key facts
| Product NDC | 51662-1249 |
|---|---|
| Proprietary name | PHENYLEPHRINE HCI |
| Nonproprietary name | PHENYLEPHRINE HCI |
| Substances | PHENYLEPHRINE HYDROCHLORIDE |
| Dosage form | INJECTION |
| Route | INTRAVENOUS |
| Labeler | HF Acquisition Co LLC, DBA HealthFirst |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Application number | NDA203826 |
| Pharmacologic classes | Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC] |
| Marketing start | Sep 16, 2018 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: